MV-LASV

N/A

Report date: 2026/01/15 20:00:17

Base Information

Drug NameMV-LASV
Drug Alias NameMV-LASV
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLassa Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThemis Bioscience Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThemis Bioscience Gmbh
Active IndicationsN/A
Inactive IndicationsLassa Fever

Other Information

ATC CodeN/A
Related LinksN/A